tiprankstipranks
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market
BCAX
Bicara Therapeutics Inc.
RESEARCH TOOLSreports

Bicara Therapeutics Inc. (BCAX) Financial Statements

77 Followers

Bicara Therapeutics Inc. Financial Overview

Bicara Therapeutics Inc.'s market cap is currently $1.38B. The company's EPS TTM is $-0.68; its P/E ratio is -6.67; Bicara Therapeutics Inc. is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -155.60M$ -82.39M$ -39.89M$ -37.66M
EBITDA$ -155.60M$ -82.33M$ -39.87M$ -37.72M
Net Income$ -137.95M$ -68.00M$ -51.98M$ -37.84M
Balance Sheet
Cash & Short-Term Investments$ 414.80M$ 489.71M$ 230.44M$ 4.16M
Total Assets$ 430.99M$ 569.20M$ 233.98M$ 6.70M
Total Debt$ 1.71M$ 738.00K$ 657.00K$ 0.00
Net Debt$ -94.97M$ -488.97M$ -229.78M$ -4.16M
Total Liabilities$ 29.54M$ 77.32M$ 15.47M$ 23.98M
Stockholders' Equity$ 401.45M$ 491.88M$ 218.51M$ -17.28M
Cash Flow
Free Cash Flow$ -107.11M$ -74.82M$ -46.21M$ -32.27M
Operating Cash Flow$ -106.83M$ -74.75M$ -45.63M$ -32.08M
Investing Cash Flow$ -318.45M$ -9.00K$ -586.00K$ -192.00K
Financing Cash Flow$ 32.26M$ 334.03M$ 272.50M$ 31.70M
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History

Income Statement >

Bicara Therapeutics Inc. Debt to Assets

Balance Sheet >

Bicara Therapeutics Inc. Cash Flow

Cash Flow >

Bicara Therapeutics Inc. Forecast EPS vs Actual EPS

Earnings >